Cholesterol Goal Attainment rate and its associated factors among dyslipidemic Patients on lipid-lowering drug therapy in Korea - CRESENDO
Study identifier:NIS-CKR-XXX-2011/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Cholesterol goal attainment rate and its associated factors among dyslipidemic patients on lipid-lowering drug therapy in Korea (CRESCENDO)
Medical condition
Dyslipidemia
Phase
-
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
4950
Study type
Observational
Age
19 Years +
Date
Study Start Date: 01 Aug 2011
Primary Completion Date: 01 Oct 2011
Study Completion Date: 01 Oct 2011
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Jan 2015 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| Dyslipidemia | - |
Contacts
Investigators
Principal Investigator
Jeong Ui Park
Samsung Medical center
